{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:16Z","timestamp":1760132176339},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00520-011-1254-1","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T16:41:21Z","timestamp":1314117681000},"page":"1639-1647","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids"],"prefix":"10.1007","volume":"20","author":[{"given":"Wendy H.","family":"Oldenmenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Lieverse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J. J. M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Taal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carin C. D.","family":"van der Rijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"issue":"9","key":"1254_CR1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH Beuken-van Everdingen van den","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40\u00a0years. Ann Oncol 18(9):1437\u20131449","journal-title":"Ann Oncol"},{"key":"1254_CR2","first-page":"1","volume":"804","author":"WHO","year":"1990","unstructured":"WHO (1990) Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 804:1\u201375","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"1254_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","volume":"63","author":"DF Zech","year":"1995","unstructured":"Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 63(1):65\u201376","journal-title":"Pain"},{"issue":"3","key":"1254_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jpainsymman.2009.06.002","volume":"38","author":"PG Fine","year":"2009","unstructured":"Fine PG, Portenoy RK, Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation (2009) Establishing \u201cbest practices\u201d for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage 38(3):418\u2013425","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"1254_CR5","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cncr.10518","volume":"94","author":"RH Enting","year":"2002","unstructured":"Enting RH, Oldenmenger WH, van der Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PA (2002) A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer 94(11):3049\u20133056","journal-title":"Cancer"},{"issue":"5","key":"1254_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpainsymman.2007.01.007","volume":"34","author":"RH Enting","year":"2007","unstructured":"Enting RH, Oldenmenger WH, Van Gool AR, van der Rijt CC, Sillevis Smitt PA (2007) The effects of analgesic prescription and patient adherence on pain in a Dutch outpatient cancer population. J Pain Symptom Manage 34(5):523\u2013531","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"1254_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.18433\/J3VC75","volume":"10","author":"MG Kumar","year":"2007","unstructured":"Kumar MG, Lin S (2007) Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms. J Pharm Pharm Sci 10(4):504\u2013518","journal-title":"J Pharm Pharm Sci"},{"issue":"5","key":"1254_CR8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative Care (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587\u2013593","journal-title":"Br J Cancer"},{"issue":"1","key":"1254_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(98)00118-3","volume":"79","author":"S Mercadante","year":"1999","unstructured":"Mercadante S (1999) Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 79(1):1\u201313","journal-title":"Pain"},{"issue":"5 Suppl","key":"1254_CR10","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","volume":"29","author":"A Murray","year":"2005","unstructured":"Murray A, Hagen NA (2005) Hydromorphone. J Pain Symptom Manage 29(5 Suppl):S57\u2013S66","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1254_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(02)00643-7","volume":"25","author":"C Quigley","year":"2003","unstructured":"Quigley C, Wiffen P (2003) A systematic review of hydromorphone in acute and chronic pain. J Pain Symptom Manage 25(2):169\u2013178","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"1254_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0885-3924(93)90128-I","volume":"8","author":"E Bruera","year":"1993","unstructured":"Bruera E, MacEachern T, Macmillan K, Miller MJ, Hanson J (1993) Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study. J Pain Symptom Manage 8(4):201\u2013204","journal-title":"J Pain Symptom Manage"},{"issue":"15","key":"1254_CR13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM199610103351507","volume":"335","author":"MH Levy","year":"1996","unstructured":"Levy MH (1996) Pharmacologic treatment of cancer pain. N Engl J Med 335(15):1124\u20131132","journal-title":"N Engl J Med"},{"issue":"9165","key":"1254_CR14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","volume":"353","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK, Lesage P (1999) Management of cancer pain. Lancet 353(9165):1695\u20131700","journal-title":"Lancet"},{"key":"1254_CR15","unstructured":"CBO, VIKC (2008) Diagnostiek en behandeling van pijn bij pati\u00ebnten met kanker. Van Zuiden Communications B.V., Alphen a\/d\/Rijn"},{"issue":"9166","key":"1254_CR16","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0140-6736(99)01309-4","volume":"353","author":"DC Turk","year":"1999","unstructured":"Turk DC, Okifuji A (1999) Assessment of patients\u2019 reporting of pain: an integrated perspective. Lancet 353(9166):1784\u20131788","journal-title":"Lancet"},{"issue":"1\u20132","key":"1254_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(97)00018-3","volume":"72","author":"P Lawlor","year":"1997","unstructured":"Lawlor P, Turner K, Hanson J, Bruera E (1997) Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 72(1\u20132):79\u201385","journal-title":"Pain"},{"issue":"4","key":"1254_CR18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T","volume":"78","author":"E Bruera","year":"1996","unstructured":"Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J (1996) Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 78(4):852\u2013857","journal-title":"Cancer"},{"issue":"2","key":"1254_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5694\/j.1326-5377.1999.tb126885.x","volume":"170","author":"MA Ashby","year":"1999","unstructured":"Ashby MA, Martin P, Jackson KA (1999) Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust 170(2):68\u201371","journal-title":"Med J Aust"},{"issue":"12","key":"1254_CR20","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/cncr.20712","volume":"101","author":"MA Benitez-Rosario","year":"2004","unstructured":"Benitez-Rosario MA, Feria M, Salinas-Martin A, Martinez-Castillo LP, Martin-Ortega JJ (2004) Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 101(12):2866\u20132873","journal-title":"Cancer"},{"issue":"3","key":"1254_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0885-3924(96)00050-4","volume":"12","author":"I Maddocks","year":"1996","unstructured":"Maddocks I, Somogyi A, Abbott F, Hayball P, Parker D (1996) Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 12(3):182\u2013189","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1254_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1191\/0269216303pm696oa","volume":"17","author":"DM Tse","year":"2003","unstructured":"Tse DM, Sham MM, Ng DK, Ma HM (2003) An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population. Palliat Med 17(2):206\u2013211","journal-title":"Palliat Med"},{"issue":"5","key":"1254_CR23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejpain.2004.12.003","volume":"9","author":"HC Muller-Busch","year":"2005","unstructured":"Muller-Busch HC, Lindena G, Tietze K, Woskanjan S (2005) Opioid switch in palliative care, opioid choice by clinical need and opioid availability. Eur J Pain 9(5):571\u2013579","journal-title":"Eur J Pain"},{"issue":"5","key":"1254_CR24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587\u2013593","journal-title":"Br J Cancer"},{"issue":"5","key":"1254_CR25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","volume":"50","author":"D Tong","year":"1982","unstructured":"Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer 50(5):893\u2013899","journal-title":"Cancer"},{"issue":"3","key":"1254_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2006.02.007","volume":"78","author":"YM Linden van der","year":"2006","unstructured":"van der Linden YM, Steenland E, van Houwelingen HC, Post WJ, Oei B, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group (2006) Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 78(3):245\u2013253","journal-title":"Radiother Oncol"},{"issue":"6266","key":"1254_CR27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.282.6266.771","volume":"282","author":"J Sawe","year":"1981","unstructured":"Sawe J, Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, Rane A, Anggard E (1981) Patient-controlled dose regimen of methadone for chronic cancer pain. Br Med J Clin Res Ed 282(6266):771\u2013773","journal-title":"Br Med J Clin Res Ed"},{"issue":"3 Suppl","key":"1254_CR28","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/0885-3924(92)90053-K","volume":"7","author":"R Slover","year":"1992","unstructured":"Slover R (1992) Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center. J Pain Symptom Manage 7(3 Suppl):S45\u2013S47","journal-title":"J Pain Symptom Manage"},{"issue":"8881","key":"1254_CR29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0140-6736(93)92228-L","volume":"342","author":"JS Morley","year":"1993","unstructured":"Morley JS, Watt JW, Wells JC, Miles JB, Finnegan MJ, Leng G (1993) Methadone in pain uncontrolled by morphine. Lancet 342(8881):1243","journal-title":"Lancet"},{"issue":"2","key":"1254_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3959(94)00257-F","volume":"62","author":"E Bruera","year":"1995","unstructured":"Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturrisi C (1995) Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62(2):141\u2013146","journal-title":"Pain"},{"issue":"7","key":"1254_CR31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","volume":"76","author":"NJ Cherny","year":"1995","unstructured":"Cherny NJ, Chang V, Frager G, Ingham JM, Tiseo PJ, Popp B, Portenoy RK, Foley KM (1995) Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 76(7):1283\u20131293","journal-title":"Cancer"},{"issue":"2","key":"1254_CR32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0304-3959(95)00084-6","volume":"63","author":"A Paix","year":"1995","unstructured":"Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, Ashby M (1995) Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 63(2):263\u2013269","journal-title":"Pain"},{"issue":"5","key":"1254_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","volume":"10","author":"ND Stoutz de","year":"1995","unstructured":"de Stoutz ND, Bruera E, Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10(5):378\u2013384","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"1254_CR34","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.1996.14.10.2836","volume":"14","author":"F Conno De","year":"1996","unstructured":"De Conno F, Groff L, Brunelli C, Zecca E, Ventafridda V, Ripamonti C (1996) Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol 14(10):2836\u20132842","journal-title":"J Clin Oncol"},{"issue":"7","key":"1254_CR35","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1428::AID-CNCR21>3.0.CO;2-0","volume":"79","author":"NA Hagen","year":"1997","unstructured":"Hagen NA, Babul N (1997) Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 79(7):1428\u20131437","journal-title":"Cancer"},{"issue":"10","key":"1254_CR36","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1200\/JCO.1998.16.10.3216","volume":"16","author":"C Ripamonti","year":"1998","unstructured":"Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F (1998) Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 16(10):3216\u20133221","journal-title":"J Clin Oncol"},{"issue":"4","key":"1254_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s005200050259","volume":"7","author":"B Gagnon","year":"1999","unstructured":"Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E (1999) The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Supp Care Cancer 7(4):265\u2013270","journal-title":"Supp Care Cancer"},{"issue":"10","key":"1254_CR38","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1200\/JCO.1999.17.10.3307","volume":"17","author":"S Mercadante","year":"1999","unstructured":"Mercadante S, Casuccio A, Calderone L (1999) Rapid switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol 17(10):3307\u20133312","journal-title":"J Clin Oncol"},{"issue":"6","key":"1254_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s005200000153","volume":"8","author":"M Kloke","year":"2000","unstructured":"Kloke M, Rapp M, Bosse B, Kloke O (2000) Toxicity and\/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center. Supp Care Cancer 8(6):479\u2013486","journal-title":"Supp Care Cancer"},{"issue":"1","key":"1254_CR40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/026921601669626431","volume":"15","author":"MA Lee","year":"2001","unstructured":"Lee MA, Leng ME, Tiernan EJ (2001) Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med 15(1):26\u201334","journal-title":"Palliat Med"},{"issue":"11","key":"1254_CR41","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","volume":"19","author":"S Mercadante","year":"2001","unstructured":"Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, Gebbia V, Ripamonti C (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19(11):2898\u20132904","journal-title":"J Clin Oncol"},{"issue":"7","key":"1254_CR42","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/1097-0142(20011001)92:7<1919::AID-CNCR1710>3.0.CO;2-G","volume":"92","author":"J Santiago-Palma","year":"2001","unstructured":"Santiago-Palma J, Khojainova N, Kornick C, Fischberg DJ, Primavera LH, Payne R, Manfredi P (2001) Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl. Cancer 92(7):1919\u20131925","journal-title":"Cancer"},{"issue":"5","key":"1254_CR43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/0269216302pm536oa","volume":"16","author":"P McNamara","year":"2002","unstructured":"McNamara P (2002) Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliat Med 16(5):425\u2013434","journal-title":"Palliat Med"},{"issue":"3","key":"1254_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0304-3959(01)00465-1","volume":"96","author":"N Moryl","year":"2002","unstructured":"Moryl N, Santiago-Palma J, Kornick C, Derby S, Fischberg D, Payne R, Manfredi PL (2002) Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain 96(3):325\u2013328","journal-title":"Pain"},{"issue":"22","key":"1254_CR45","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1200\/JCO.2005.13.128","volume":"23","author":"S Mercadante","year":"2005","unstructured":"Mercadante S, Ferrera P, Villari P, Casuccio A (2005) Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23(22):5229\u20135234","journal-title":"J Clin Oncol"},{"issue":"1","key":"1254_CR46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2004.12.010","volume":"30","author":"T Morita","year":"2005","unstructured":"Morita T, Takigawa C, Onishi H, Tajima T, Tani K, Matsubara T, Miyoshi I, Ikenaga M, Akechi T, Uchitomi Y, Japan Pain RPMaP-OSG (2005) Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manage 30(1):96\u2013103","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"1254_CR47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jjco\/hyn010","volume":"38","author":"M Narabayashi","year":"2008","unstructured":"Narabayashi M, Saijo Y, Takenoshita S, Chida M, Shimoyama N, Miura T, Tani K, Nishimura K, Onozawa Y, Hosokawa T, Kamoto T, Tsushima T, Advisory Committee for Oxycodone Study (2008) Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. Jpn J Clin Oncol 38(4):296\u2013304","journal-title":"Jpn J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1254-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T08:50:51Z","timestamp":1560502251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,23]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1254-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,23]]}}}